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A general method for the detection of large
CAG repeat expansions by fluorescent PCR
Jon P Warner, Lilias H Barron, David Goudie, Kevin Kelly, David Dow,
David R Fitzpatrick, David J H Brock
Abstract
The expansion ofa tandemly repeated tri-
nucleotide sequence, CAG, is the muta-
tional mechanism for several human
genetic diseases. We present a generally
applicable PCR amplification method
using a fluorescently labelled locus specific
primer flanking the CAG repeat together
with paired primers amplifying from mul-
tiple priming sites within the CAG repeat.
Triplet repeat primed PCR (TP PCR)
gives a characteristic ladder on the fluor-
escence trace enabling the rapid iden-
tification of large pathogenetic CAG
repeats that cannot be amplified using
flanking primers. We used our method to
test a cohort of 183 people from myotonic
dystrophy families including unaffected
subjects and spouses. Eighty five clinically
affected subjects with expanded alleles on
Southern blot analysis were all correctly
identified by TP PCR. This method is ap-
plicable for any human diseases involving
CAG repeat expansions.
(JMed Genet 1996;33:1022-1026)
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The expansion of the trinucleotide sequence
CAG is the mutational mechanism for several
human genetic diseases including myotonic
dystrophy, Huntington's disease, spinocere-
bellar ataxia I and III, and dentatorubral-
palludoluysian atrophy.`'5 Currently, for these
diseases, PCR using flanking primers allows
amplification up to approximately 100 CAG
repeats but is unreliable above this size. The
diagnostic threshold for this series of diseases
is at between 40 to 50 repeats with alleles
above this size being in the affected range.The
myotonic dystrophy CAG repeat can expand
to give alleles of greater than 5 kb.1 PCR am-
plification of DNA from an affected person
carrying such an expansion gives a single nor-
mal allele and fails to pick up a larger allele.
For people apparently homozygous for small
common repeat size, the presence of a large
unamplifiable allele can be excluded by per-
forming a Southern blot and probing with a
locus specific fragment flanking or containing
the CAG repeat. We have developed a simple
fluorescent PCR system that can rapidly
identify but not size the largest alleles for any
disorder with a CAG repeat expansion. This
will reduce the number of Southern blot ana-
lyses required by allowing the identification of
people homozygous for smaller alleles. Samples
with large CAG expansions identified by TP
PCR will, however, still require Southern blot-
ting if an accurate estimation of size is needed.
Materials and methods
PCR DESIGN
Traditionally, PCR amplification of these un-
stable DNA sequences involves the use of a
pair of locus specific primers (P1, P2) that
flank the variable trinucleotide sequence. Our
PCR assay uses a specific flanking fluorescently
labelled primer (P1) in concert with a pair of
primers (P3, P4) which have a common 5'
sequence (tail) (fig 1). The common 5'
sequence or tail primer (P3) was selected
from an artificially produced random DNA
sequence. The selection criteria for the
sequence of the tail primer were (1) that it
should contain little or no selfcomplementarity,
(2) no complementarity with either (GCA)5 or
(TGC)5, and (3) no homology to known human
sequences. The paired primer (P4) has the
sequence (GCA)5 or (TGC)5 at its 3' terminus
depending on the strand of the CAG repeat to
be amplified.
In the early amplification cycles the repeat
specific 3' terminus of P4 primes at multiple
sites within CAG repeat alleles giving rise to a
mixture of products. Specificity is dictated by
the fluorescent locus specific primer (P1). A
10:1 molar ratio ofP3 to P4 ensures that primer
P4 is exhausted in the early amplification cycles.
This reduces priming at (CAG)n sites internal
to the PCR products produced in earlier
rounds, which would result in a gradual short-
ening of the average PCR product size (fig 1).
The phenomenon of maintaining the allele size
distribution by using a combination of tailed
primer pairs was first described by Neil and
Jeffreys2 in the context of satellite DNA repeat
amplification. The primer P3 preferentially
binds to the end of products from previous
amplification rounds owing to the stabilising
effect of the 5' tail sequence. A long extension
time is used to allow complete extension of the
larger sized products within the PCR product
mixture.
POLYMERASE CHAIN REACTION
DNA used for PCR amplification was extracted
from venous blood leucocytes using standard
DNA extraction methods. Primer sequences
are shown in table 1. The sequences of HD 1
and DRPLA 2 were selected from the HD'
and DRPLA5 gene sequences respectively. P1
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conventional ampli&fation ofthe myotonic dys-
trophy CAG repeat, mix B: P 1 (5' fluor-
esceinated 1 pmol/l) with P3R (1 pmol/l) and
P4CTG (0.1Ipmol/l), and mix C: P2 (5' fluor-
esceinated 1 jimol/l) with P3 (1 jimol/l) and
P4CAG (0.1 imol/l) for amplifications priming
from the CAG repeat allele. Samples were
overlaid with mineral oil (Sigma) and incubated
for four minutes at 94°C before the addition
of the Taq polymerase. The reactions were
subjected to 30 cycles of 94°C for one minute,
60°C for one minute, and 72°C for two minutes
followed by a 10 minute extension at 72°C in
a Perkin Elmer DNA thermal cycler.
Five microlitres of each PCR product were
added to 5 pl of distilled water and 10 pl of
loading buffer (10 mg/ml blue dextran in de-
ionised formamide) and incubated at 95°C for
three minutes. Tubes were cooled on ice before
loading on a denaturing 6% polyacrylamide
7 mol/l urea gel. PCR products were resolved
by electrophoresis in 0.6 x TBE and visualised
using an automatic laser fluorescent sequencer
(ALF Pharmacia). Traces were analysed using
the Pharmacia fragment manager software.
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Figure 1 Design details for internally primed repeat specific PCR. Stippled box represents
(CAG)n repeat. F shows 5' fluoresceinated primer. (A) For large alleles exceeding 100
CAG repeats the PCR using flanking primers Pl and P2 fails to give a product. (B) In
the early amplification cycles primer the repeat specific 3' terminus ofP4 binds at multiple
sites within CAG repeat alleles giving rise to a mixture ofproducts. Specificity is dictated
by the fluorescent locus specific primer (Pl). A 10:1 molar ratio ofP3 to P4 ensures that
primer P4 is exhausted in the early amplification cycles. (C) The primer P3 amplifies
from the end ofproducts from previous amplification rounds. A long extension time is used
to allow complete extension of the larger sized products within the PCR product mixture
and conserve the representation of the longer products.
and P2 were selected from the 3' non-coding
region of the myotonin protein kinase gene
DNA sequence.' The primers flank the myo-
tonin CAG repeat, have matched annealing
temperatures, and are also appropriate for am-
plification in conjunction with the primers P3R,
P4CTG, and P4CAG. PCR reactions were
performed in 25 gl reaction volumes. The fol-
lowing buffer components were found to give
optimal amplification: 1.5 mmol/l MgCl2,
1O mmol/l Tris HC1, pH 8.3, 50 mmol/I KC1,
10% DMSO, 200 gmol/l dATP, 200 j.mol/I
dCTP, 200 jmol/I dGTP, and 200 jmol/I
dTTP. Genomic DNA (200 ng-1 I,g) and ap-
proximately 2 U of Taq polymerase (Cetus)
were used for each reaction. The following
primer combinations were used. Mix A: P1 (5'
Table 1 Primer sequences
Primer Sequence (5'-3')
P1 AGA AAG AAA TGG TTC TGT GAT CCC
P2 GAA CGG GGC TCG AAG GGT CCT TGT AGC CG
P3R TAC GCA TCC CAG Tl-T GAG ACG
P4CTG TAC GCA TCC GAG lTT GAG ACG TGC TGC TGC TGC TGC T
P4CAG TAC GCA TCC CAG FF1T GAG ACG CAG CAG CAG CAG CAG CA
HDI ATG AAG GCC FTC GAG TCC CTC AAG TCC FTC
DRPLA 2 TGCA CCA TCA CCA CCA GCA ACA GCA A
SUBJECTS
Blood samples from 183 people from 48 myo-
tonic dystrophy families had been collected
by the Clinical Genetics Department in Ed-
inburgh. DNA had been extracted and banked
by the Molecular Genetics Service Laboratory
in Edinburgh. DNA samples had been sent for
Southern and conventional PCR analysis by
another Scottish Molecular Genetics Con-
sortium member laboratory in Aberdeen. This
cohort included samples from unaffected
people and spouses. The samples had been
banked with no indication of the disease status
of individual family members. The DNA
samples were tested using PCR mixes A and
B and scored blind.
Results and discussion
Typical traces obtained using mix A are shown
in fig 2. The PCR amplification across the
myotonin CAG repeat gives reliable am-
plification up to alleles of approximately 100
CAG repeats but fails to amplify above this
size. Analysis ofseverely affected myotonic dys-
trophy patients by genomic Southern blotting
typically shows expansions between 1.5 and
4 kb. PCR amplification of DNA from an
affected subject carrying such an expansion
gives a single normal allele and fails to pick up
a larger allele, and is thus indistinguishable
from patients genuinely homozygous for a small
allele.
Typical traces obtained using mix B are
shown in figs 3 and 4. Mix B gives similar
traces to mix C (not shown). Amplification
products show a characteristic ladder with a
three base pair periodicity when products are
analysed on a laser fluorescence DNA
sequencer. The ladder peaks at the size of the
largest allele present or, for very large repeat
alleles, the peak height diminishes gradually
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Figure 2 PCR amplification at the myotonin locus using flanking primers. The axis
shows migration time in minutes. CAG allele sizes shown with the arrows. (A) Trace
obtained from a heterozygous normal subject. (B) Trace obtained from a heterozygous
subject with a small expansion. (C) Trace obtained from a patient with myotonic
dystrophy and an expanded allele size of >4 kb as determined by Southern blot analysis.
The larger allele fails to amplify.
with increasing product size (fig 4). Allele sizes
were determined by comparing with amplified
PCR product from a person whose myotonin
CAG alleles had been cloned and sequenced.
Once a reference point is established, the three
base pair periodicity of the ladder for the mix
B traces gives an excellent size ladder for use
with both systems, as the internally primed
PCR products are smaller than the products
obtained using the flanking primers.
Of the 183 samples that were tested with
PCR mix A, four were found to have CAG
repeat allele between 50 and 89 CAG repeats
in the small affected allele size range. When
these four samples were tested with mix B
they gave the characteristic ladder with a 3 bp
periodicity which extended to and peaked at
the expected allele size for the larger allele (figs
3 and 4, central trace). A further 72 samples
that had given one normal CAG repeat allele
with mix A gave the characteristic ladder which
extended beyond 50 CAG repeats with the peak
height diminishing with increasing product size
(figs 3 and 4, bottom trace). These 76 people
were scored as affected with myotonic dys-
trophy with CAG repeat alleles of greater than
50 CAG repeats. The remaining 107 DNA
samples did not give the long characteristic
ladder seen for large CAG expansions with mix
B. Amplification with mix A showed that 76
people were heterozygous for CAG repeat al-
leles in the normal range with 31 patients
homozygous for alleles in the normal range.
The clinical status of the patients and the
results of the PCR and genomic Southern ana-
lysis reported by the Aberdeen laboratory were
consulted. A total of 74 of the 76 people with
CAG repeat alleles in the affected range were
symptomatic and classed with an affected dis-
ease status. Two patients had alleles just within
the affected range and were as yet asympto-
matic. Both had either children or close rel-
atives affected with myotonic dystrophy in
whom we had also detected expanded CAG
repeat alleles. The results of the conventional
DNA analysis were that 75 patients had ex-
panded CAG alleles in the affected range, from
50 CAG repeats to expansions of >5 kb. All
75 were in the group of 76 patients for whom
our PCR assay had given evidence for the
presence of a large CAG repeat allele. The
one patient we identified who had not been
ascertained by conventional testing was said to
be clinically affected. The result ofthe Southern
analysis for this DNA had been ambiguous
because of poor DNA quality and a fresh
sample will be collected for retesting.
On the basis of this series of tests we are
confident that our TP PCR test for myotonic
dystrophy is robust and reliable. For this large
cohort of patients we obtained no false negative
results and the results we obtained showed
absolute concordance with the results obtained
by conventional means. The only difference we
saw suggested that our method was able to
identify expanded alleles in poor quality DNA
samples where Southern analysis failed to give
a reliable result. This method does not measure
the size of large expanded CAG repeat alleles
but reliably identifies their presence. DNA
samples can be screened using this method and
only samples with large expansions would need
to be analysed further using genomic Southern
blotting in order to establish the exact size of
large expanded alleles. The recently described
XL PCR based method of Cheng et alt could
be used for samples where insufficient DNA
for Southern analysis is available. This method
is, however, technically demanding and labour
intensive as PCR products are resolved by agar-
ose gel electrophoresis, the gel being then blot-
ted and probed with a locus specific probe.
Our TP PCR method works if the fluorescent
primer P1 is replaced by 32P end labelled P1.
These radiolabelled products are, however,
more difficult to size accurately in the 30 to
60 CAG repeat size range (data not shown).
Obviously silver staining is inappropriate for
TP PCR as many non-specific inter(CAG)n
products are generated.
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A We have carried out some pilot TP PCR
_0- experiments using specific flanking primers for
5 CAG other diseases where expanded CAG repeats
are the mutational mechanism. For Hun-
tington's disease the same PCR conditions as
described above for mix B replacing the primerNormal alleles P1 with HD17 give reliable results (not shown).
It has been suggested that for people with
_ 11 CAG juvenile onset of Huntington's disease, where
an expanded allele appears to be absent and
\1Jllthe patient is homozygous for a smaller allele,a Southern analysis should be performed to
exclude the presence of an unamplifiable large
allele (Clinical Molecular Genetics Society of
B Great Britain, personal communication, 1995).
11 CAG Despite never having failed to amplify bothalleles for juvenile Huntington's disease re-
ferrals up to 96 CAG repeats using flanking
primers in Edinburgh, we would recommend
the use of TP PCR to show the presence ofl|11g1Small expansion these large, more difficult to amplify alleles.
Similarly, we have shown that reliable results
are obtained for large alleles for DRPIA when
J11050 CAG the primer DRPLA replaces P2 in mix C.
In conclusion we have developed a novel
PCR assay that can be used for screening for
expanded CAG repeat alleles including full
C mutation alleles of >5 kb in myotonic dys-
trophy. TP PCR is robust and reliable and can
in theory also be used in conjunction with locus
specific flanking primers for any disease with a
similar mutational mechanism.
We would like to thank all the clinicians who have sent us the
Full expansion samples over the years and Aileen Crosbie for help with clinical
records.
(cont. overleaj)
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Figure 3 PCR amplification at the myotonin locus using internal primers. The axis
shows migration time in minutes. CAG allele sizes shown with the arrows. The same
people typed in fig 2 were retyped using mix B. Note the characteristic ladder with a 3 bp
periodicity. (A) Both alleles give peaks and all the intermediate priming sites give peaks.
There is a slight continuation of the pattern beyond the maximum allele size owing to
mispriming at the end of the repeat. This usually extends for less than 30 bp. (B) Both
alleles give peaks as in (A). (C) The ladder shows the presence of a large CAG allele
undetectable using flanking primers.
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Figure 4 Close up of traces shown in fig 3. The axis shows migration time in minutes.
CAG allele sizes shown with the arrows. (A) Detail from trace shown in fig 3B. (B)
Detail from trace shown in fig 3C.
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